Pembrolizumab (Ingredient)
Drugbank ID: DB09037
ATC code: L01XC18
The information below refers to products available in the United States that contain pembrolizumab.
Products containing pembrolizumab
pembrolizumab systemic
Brand name: Keytruda
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Pembrolizumab systemic is used in the treatment of:
- Biliary Tract Tumor
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Head and Neck Cancer
- Hepatocellular Carcinoma
- Hodgkin's Lymphoma
- Melanoma
- Melanoma, Metastatic
- Merkel Cell Carcinoma
- Non Small Cell Lung Cancer
- Ovarian Cancer
- Primary Mediastinal Large B-cell Lymphoma
- Renal Cell Carcinoma
- Solid Tumors
- Squamous Cell Carcinoma
- Urothelial Carcinoma
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
